10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 small-cap stocks to buy according to billionaire Steve Cohen.
Arcutis Biotherapeutics Inc. (ARQT)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 6,073,850 | $116,982 | 1.89% | |
| 2. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,784,005 | $34,360 | 0.15% | |
| 3. | Point72 Asset Management Steve Cohen | 1,697,849 | $32,701 | -36% | 0.12% |
| 4. | Logos Capital Arsani William | 1,500,000 | $28,890 | +500% | 3.74% |
| 5. | EcoR1 Capital Oleg Nodelman | 895,503 | $17,247 | 0.53% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing | |
| $25.00 | 200,000 | Large Shareholder, Director | 4,267,564 | 2020-10-02 | Filing | |
| $25.00 | 296,000 | Large Shareholder, Director | 902,286 | 2020-10-02 | Filing | |
| $25.00 | 200,000 | Large Shareholder, Director | 4,267,564 | 2020-10-02 | Filing | |
| $17.00 | 294,117 | Large Shareholder | 3,979,292 | 2020-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.31 | 35,944 | Large Shareholder | 415,142 | 2022-06-24 | Filing | |
| $21.31 | 306,027 | Large Shareholder | 3,534,537 | 2022-06-24 | Filing | |
| $21.06 | 1,000 | Officer, Director | 659,284 | 2022-06-06 | Filing | |
| $19.73 | 1,795 | Officer | 16,380 | 2022-06-02 | Filing | |
| $20.62 | 2,500 | Director | 181,896 | 2022-06-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 35,265 | $679,000 | 0.01% | |
| 2. | 29,972 | $577,261 | 0% | |
| 3. | 8,434,232 | $162,443 | 13.84% | |
| 4. | 7,557,593 | $145,558 | 0.01% | |
| 5. | 4,315,802 | $83,124 | 0% |
News See All
Is ARQT A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Arcutis Biotherapeutics, Inc. (ARQT) Going to Burn These Hedge Funds?
In this article you are going to find out whether hedge funds think Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is a good investment right now.
Billionaire Hedge Funds
